The NHS hip and knee replacement conversation is fundamentally about waiting time, not eligibility. Primary arthroplasty is NHS-funded under standard adult orthopedic commissioning where conservative management has failed and clinical / radiographic indication for joint replacement is established. The cost-question conversation starts when the patient considers UK private self-pay or a coordinated international pathway over the NHS elective wait — currently averaging around 27 weeks (~6 months) for hip replacement nationally, with substantial regional variation pushing some ICBs past 12 months for non-urgent cases.
NHS funds primary hip and knee arthroplasty under standard adult orthopedic commissioning where conservative management (physiotherapy, NSAIDs, intra-articular steroid injection) has failed and there is clinical and radiographic indication for joint replacement: typically end-stage osteoarthritis, advanced rheumatoid arthritis, post-traumatic osteoarthritis, or avascular necrosis. The procedure itself is NHS-funded; the waiting time is the binding constraint.
Per NHS England RTT data, the national hip replacement average wait is approximately 27 weeks (around 6 months); the median across all procedures sits at 13.9 weeks. Only 61.6% of patients begin treatment within 18 weeks against the NHS standard of 92%. Underperforming Integrated Care Boards report 12 to 18 months for non-urgent cases, and the slowest tail can extend further. NHS England elective recovery plan targets remain unmet for orthopedic surgery as of 2026. Patients facing the wait have three options: continue conservative management while waiting, pursue UK private self-pay (from £8,500), or consider a coordinated international pathway.
Even where the clinical criteria are met, NHS hip and knee replacement waiting times vary sharply by Integrated Care Board. Some ICBs report 9 to 12 months; others report 18 to 24 months. The patient's GP referral and the receiving NHS orthopedic service determines actual access. Practice Plus Group and other NHS-private hybrid centres carry some patients NHS-side under contract; private self-pay starts when the patient declines the receiving ICB's wait.
Most ICBs apply pre-operative BMI optimisation thresholds (typically BMI ≤ 35 or ≤ 40 absolute ceiling), smoking cessation requirements (3 to 6 months pre-op), and conservative-management documentation (physiotherapy, weight loss, NSAID trial) before adding the patient to the elective list. NICE NG157 (osteoarthritis clinical guideline) informs the threshold; specific ICB policy varies.
NHS funds revision arthroplasty (replacement of a previous implant due to wear, loosening, infection, or malposition) but waiting times are similar to primary arthroplasty for non-urgent cases; complex revisions are referred to tertiary centres with sub-specialty revision arthroplasty surgeons.
UK private hip and knee replacement self-pay typically starts when the patient declines the NHS waiting list — the procedure is the same, the surgeon may be the same NHS orthopedic consultant in their private session, but the waiting time drops from a national average of around 27 weeks (or longer in underperforming ICBs) to 4 to 8 weeks. Cost moves from £0 (NHS) to £8,500 to £16,500 (UK private, full distribution) or £4,500 to £7,000 (ATDERA Care Network coordinated Turkey pathway).
